Vanderbilt Heart and Vascular Institute Archives
Aug. 8, 2013—Vanderbilt Heart and Vascular Institute is the first in the United States to use a new fully resorbable “envelope” that encloses implantable cardiac devices, such as pacemakers and internal cardioverter defibrillators (ICDs), and helps prevent surgical site infections.
Aug. 1, 2013—People with the most common irregular heart rhythm known as atrial fibrillation (AF) are at greater risk for stroke due to the formation of clots in the left atrial appendage (LAA), a small pouch which empties blood into the left atrium.
Jul. 18, 2013—Vanderbilt Heart and Vascular Institute physicians are taking advantage of new technology in critical care that allows them to quickly visualize the patient’s heart at the bedside.
May. 9, 2013—Peggi Angel, Ph.D., research instructor in Biochemistry, studies congenital aortic valve stenosis in children. It’s a disease where the heart valve, which is normally very thin, becomes bloated with extracellular matrix. This occurs rapidly in some children but not in others.
Apr. 25, 2013—During Cardiovascular Research Day, keynote speaker Sekar Kathiresan, M.D., second from left, associate professor of Medicine, Harvard Medical School, visits with Vanderbilt Heart and Vascular Institute’s Sergio Fazio, M.D., Ph.D., left, MacRae Linton, M.D., Thomas Wang, M.D., David Harrison, M.D., and Dan Roden, M.D.
Apr. 25, 2013—Vanderbilt Heart and Vascular Institute is participating in a clinical study to further evaluate the safety and feasibility of rapidly lowering the body’s temperature to significantly reduce the amount of damage caused by a heart attack.
Apr. 11, 2013—The state of Michael Stanbery’s health was shocking.
Mar. 14, 2013—Over the next three years, Medicare will test a new payment arrangement that rewards participating hospitals when Medicare patients require fewer inpatient and post-discharge services, but extracts financial penalties when patients require more of these services.
Mar. 7, 2013—Life just got a little easier for Vanderbilt patients with structural heart disease.
Feb. 21, 2013—Keith Churchwell, M.D., executive director and chief medical officer of Vanderbilt Heart and Vascular Institute, addressed his colleagues on Valentine’s Day at the quarterly Town Hall. Patient visits to Vanderbilt Heart’s main campus clinic are projected to be on budget for the fiscal year at 130,000, he reported.
Dec. 20, 2012—Doug Sawyer, M.D., Ph.D., Lisa M. Jacobson Chair of Cardiovascular Medicine and Professor of Medicine and Pharmacology, will step down as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute (VHVI), effective April 1, 2013. Sawyer will continue to pursue his clinical, teaching and research endeavors at VHVI....